Share on StockTwits

Arca Biopharma (NASDAQ:ABIO) announced its earnings results on Thursday. The company reported ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by $0.01, AnalystRatings.Net reports.

On a related note, analysts at Zacks reiterated an “outperform” rating on shares of Arca Biopharma in a research note on Friday, March 21st. They now have a $3.00 price target on the stock.

Arca Biopharma (NASDAQ:ABIO) opened at 1.43 on Thursday. Arca Biopharma has a one year low of $1.13 and a one year high of $2.54. The stock’s 50-day moving average is $1.53 and its 200-day moving average is $1.72. The company’s market cap is $30.0 million.

ARCA biopharma, Inc (NASDAQ:ABIO) is a biopharmaceutical company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.